Atara Biotherapeutics, Inc.: Form SCHEDULE 13D/A, filed Aug 19, 2025
Filed with the SEC on Aug 19, 2025 and accepted by EDGAR at Aug 19, 2025, 20:15 ET.
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Source: SEC EDGAR, the filing index for accession 0000950170-25-110311. Last ingested by Listed: Oct 24, 2026, 15:14 ET. Listed shows no prices and gives no investment advice.